The comprehensive landscape of miR-34a in cancer research

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Cancer Metastasis Review

• Publication date

  2021-05-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10555-021-09973-3PMID 33959850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of TP53 rs1042522 C>G and miR‐34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven‐center case–control study

  2020cited by this paper
• Comparative Toxicogenomics Database (CTD): update 2021

  2020cited by this paper
• MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

  2019cited by this paper
• TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.

  2019cited by this paper
• Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis

  2019cited by this paper
• miR-34b/c rs4938723 T>C Decreases Neuroblastoma Risk: A Replication Study in the Hunan Children

  2019cited by this paper
• KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome

  2019cited by this paper
• Aberrant Promoter Hypermethylation of Mir34a and Mir200b Genes in Pediatric Acute Lymphoblastic Leukemia

  2019cited by this paper
• Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers

  2019cited by this paper
• Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway.

  2019cited by this paper
• Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.

  2018cited by this paper
• Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a

  2018cited by this paper
• ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma

  2018cited by this paper
• MiR-34 inhibits polycomb repressive complex 2 to modulate chaperone expression and promote healthy brain aging

  2018cited by this paper
• MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis

  2018cited by this paper
• Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma

  2018cited by this paper
• miR-34a directly targets tRNAiMet precursors and affects cellular proliferation, cell cycle, and apoptosis

  2018cited by this paper
• MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1

  2018influential reference
• MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter

  2018cited by this paper
• lncRNA C2dat1 Promotes Cell Proliferation, Migration, and Invasion by Targeting miR-34a-5p in Osteosarcoma Cells

  2018cited by this paper
• MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration

  2018cited by this paper
• Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion

  2018cited by this paper
• Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.

  2018cited by this paper
• Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer.

  2018cited by this paper
• Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma

  2018cited by this paper
• MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis

  2018cited by this paper
• Knockdown of long non‐coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR‐34a

  2018cited by this paper
• Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway.

  2018cited by this paper
• Long noncoding RNA UFC1 is activated by E2F1 and exerts oncogenic properties by functioning as a ceRNA of FOXP3

  2018cited by this paper
• Long non-coding RNA XIST exerts oncogenic functions in pancreatic cancer via miR-34a-5p

  2018cited by this paper
• Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

  2018cited by this paper
• miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.

  2018cited by this paper
• MicroRNA-34a inhibits liver cancer cell growth by reprogramming glucose metabolism

  2018cited by this paper
• Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas

  2018cited by this paper
• Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a

  2018cited by this paper
• Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer

  2018cited by this paper
• Association of Common Genetic Variants in Pre-microRNAs and Neuroblastoma Susceptibility: A Two-Center Study in Chinese Children

  2018cited by this paper
• Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression

  2018cited by this paper
• A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c.

  2018cited by this paper
• MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to luteolin by directly targeting HK1.

  2018cited by this paper
• IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis

  2018cited by this paper
• LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling

  2018cited by this paper
• MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.

  2018cited by this paper
• Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p

  2018cited by this paper
• Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.

  2017cited by this paper
• LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1/E2F3 pathway

  2017cited by this paper
• miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression

  2017cited by this paper
• The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis

  2017cited by this paper
• Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells

  2017cited by this paper
• miR-34a and miR-34b/c Suppress Intestinal Tumorigenesis.

  2017cited by this paper
• MiR-34 a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB 1 in Acute Myeloid Leukemia Cells

  2017cited by this paper
• IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis

  2017cited by this paper
• The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis

  2017cited by this paper
• Abstract 5452: Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: Persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

  2017cited by this paper
• PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.

  2017cited by this paper
• Unravelling a p73-regulated network: The role of a novel p73-dependent target, MIR3158, in cancer cell migration and invasiveness.

  2017cited by this paper
• MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs

  2017cited by this paper
• Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.

  2017cited by this paper
• MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.

  2017influential reference
• The epigenetically-regulated miR-34a targeting c-SRC suppresses RAF/MEK/ERK signaling pathway in K-562 cells.

  2017cited by this paper
• miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal

  2017cited by this paper
• The Rs4938723 Polymorphism Reduces Expression of MicroRNA-34b and Increases the Risk of Recurrence after Endoscopic Dissection in Early Gastric Cancer

  2017cited by this paper
• Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a.

  2017cited by this paper
• miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness

  2017cited by this paper
• The long non-coding RNA NEAT1 enhances epithelial-to-mesenchymal transition and chemoresistance via the miR-34a/c-Met axis in renal cell carcinoma

  2017cited by this paper
• An ATP-Responsive Codelivery System of Doxorubicin and MiR-34a To Synergistically Inhibit Cell Proliferation and Migration.

  2017cited by this paper
• Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly

  2017cited by this paper
• MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells

  2017cited by this paper
• Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway

  2017cited by this paper
• Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.

  2017cited by this paper
• MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma

  2017cited by this paper
• Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.

  2017cited by this paper
• Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma

  2017cited by this paper
• Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.

  2017cited by this paper
• Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

  2017cited by this paper
• The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene

  2017cited by this paper
• MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis

  2017cited by this paper
• miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1

  2017cited by this paper
• Clinical significance of miR-34a expression in thyroid diseases – an 18F-FDG PET-CT study

  2017cited by this paper
• miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.

  2017cited by this paper
• miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway

  2017cited by this paper
• circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a

  2017cited by this paper
• Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression

  2017cited by this paper
• MiR‐34a modulates ErbB2 in breast cancer

  2017cited by this paper
• The potential of microRNAs as human prostate cancer biomarkers: A meta‐analysis of related studies

  2017cited by this paper
• MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer

  2017cited by this paper
• Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.

  2017cited by this paper
• miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma.

  2017cited by this paper
• EZH2 coupled with HOTAIR to silence MicroRNA‐34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma

  2017cited by this paper
• Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.

  2017cited by this paper
• Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer.

  2017cited by this paper
• Circulating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer.

  2017cited by this paper
• MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma

  2016cited by this paper
• miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.

  2016cited by this paper
• Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs

  2016cited by this paper
• Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells

  2016cited by this paper
• Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.

  2016cited by this paper
• Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs

  2016cited by this paper
• MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

  2016cited by this paper
• MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene

  2016cited by this paper

• Feature Screening for High-Dimensional Data with Measurement Errors using Adjusted Martingale Difference Correlation

  2026cites this paper
• MicroRNA Binding Site Polymorphisms in Hepatocellular Carcinoma: Implications for Pathogenesis, Prognosis, and Therapeutic Response

  2025cites this paper
• Mesoporous Silica-mediated Chonglou Saponin Inhibits Esophageal Cancer Cells Growth Through Regulating Fibroblast Growth Factor 19/Fibroblast Growth Factor 19 Signaling Axis

  2025cites this paper
• Prolonged Survival with Dieting for Improved Autophagy

  2025cites this paper
• Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications.

  2025cites this paper
• Elimination of carryover contamination and detection of DNA methylation based on multiplex lateral flow assay

  2025cites this paper
• Decoding the Epigenome: Comparative Analysis of Uterine Leiomyosarcoma and Leiomyoma

  2025cites this paper
• Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications

  2025cites this paper
• Hemagglutinating virus of Japan envelope encapsulating microRNA-34a-5p robustly induces apoptosis of malignant meningioma cells by suppressing survivin

  2025cites this paper
• Molecular insight into the therapeutic potential of miR-34a in retinoblastoma

  2025cites this paper
• p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p

  2025influential citation
• Association of the pri-miR-34b/c rs4938723 T > C polymorphism with hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study

  2025cites this paper
• MiR-34a rs2666433 and cognitive function in major depressive disorder: a clinical correlation analysis

  2025cites this paper
• The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors

  2025cites this paper
• Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer.

  2025cites this paper
• Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance

  2025cites this paper
• Profiling the cell-specific small non-coding RNA transcriptome of the human placenta

  2025cites this paper
• Integration of MicroRNAs with nanomedicine: tumor targeting and therapeutic approaches

  2025cites this paper
• Transcriptome Analyses Reveal the Important miRNAs Involved in Immune Response of Gastric Cancer

  2025cites this paper
• MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer

  2025cites this paper
• Metformin suppresses breast cancer cell proliferation and liver metastasis by up-regulating miR-34a

  2025cites this paper
• miR-34a-5p modulation of polycystic ovary syndrome via targeting the NOTCH signaling pathway

  2025cites this paper
• Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion

  2025cites this paper
• AXL promotes malignant phenotypes in tumor cells and might be a potential antitumor target of natural products

  2025cites this paper
• Mechanisms and technologies in cancer epigenetics

  2025cites this paper
• miR-34 as a Critical Regulator in Ovarian Cancer.

  2025cites this paper
• Circulating microRNAs as the achilles forte of diagnostics and prognostics in acute graft versus host disease following allogeneic hematopoietic stem cell transplantation

  2024cites this paper
• Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia

  2024cites this paper
• Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism

  2024cites this paper
• Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets

  2024cites this paper
• Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo

  2024cites this paper
• Liver-derived Exosomal miRNA in NAFLD: Mechanisms of Action, Biomarkers, and Therapeutic Applications.

  2024cites this paper
• MiR-128-3p – a gray eminence of the human central nervous system

  2024cites this paper
• Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis

  2024cites this paper
• A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment

  2024cites this paper
• Blocking lncRNA HCG18 re-sensitizes Taxol resistant lung cancer cells to Taxol through modulating the miR-34a-5p/HDAC1 axis

  2024cites this paper
• Serum miR-124a and miR-34a as Potential Biomarkers for Rheumatoid Arthritis

  2024cites this paper
• Differential Impairment Mechanism of Sperm Production via Induction of miR-34c-Activated Apoptosis and Spermatogenesis Pathway in Diet-Induced Obesity and Resistant Mice and GC-1 Spg Cells

  2024cites this paper
• miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses

  2024cites this paper
• Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy.

  2024cites this paper
• Combination of microRNA and suicide gene for targeting Glioblastoma: Inducing apoptosis and significantly suppressing tumor growth in vivo

  2024cites this paper
• Investigation of the regulation of EGF signaling by miRNAs, delving into the underlying mechanism and signaling pathways in cancer.

  2024cites this paper
• Revolutionizing cancer therapy: nanoformulation of miRNA-34 – enhancing delivery and efficacy for various cancer immunotherapies: a review

  2024cites this paper
• MicroRNA-34a negatively regulates Netrin1 and mediates MEK/ERK pathway to regulate chemosensitivity of gastric cancer cells

  2024cites this paper
• siRNA-based strategies to combat drug resistance in gastric cancer

  2024cites this paper
• The Chicken HDAC4 Promoter and Its Regulation by MYC and HIF1A

  2024cites this paper
• MicroRNAs and long non-coding RNAs In T-cell lymphoma: Mechanisms, pathway, therapeutic opportunities.

  2024cites this paper
• Combination of Curcumin and Zerumbone Improves VEGF-A Inhibition in Colorectal Cancer In Vivo and In Vitro Model

  2023cites this paper
• circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling.

  2023cites this paper
• Therapeutic actions of tea phenolic compounds against oxidative stress and inflammation as central mediators in the development and progression of health problems: A review focusing on microRNA regulation

  2023cites this paper
• Sirtuin1-p53: a potential axis for cancer therapy.

  2023cites this paper
• p53/MicroRNA-34 axis in cancer and beyond.

  2023cites this paper
• Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature

  2023cites this paper
• Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells

  2023cites this paper
• MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway

  2023cites this paper
• Hypericin-Mediated Regulation of miR21 and miR34a and Their Target Genes in MCF7 Breast Cancer Cells

  2023cites this paper
• Aberrant expression and regulatory role of histone deacetylase 9 in vascular endothelial cell injury in intracranial aneurysm

  2023cites this paper
• Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort

  2023cites this paper
• Expression and Regulatory Mechanisms of MicroRNA in Cholesteatoma: A Systematic Review

  2023cites this paper
• MiR-34a-Functionalized Hydroxyapatite by Lyophilization Promoted Bone Regeneration in Irradiated Bone Defects

  2023cites this paper
• Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model

  2023cites this paper
• MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential

  2023influential citation
• Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation

  2023cites this paper
• Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1

  2023cites this paper
• miR-34a-FOXP1 Loop in Ovarian Cancer

  2023cites this paper
• The impact of microRNAs on the resistance of breast cancer subtypes to chemotherapy.

  2023cites this paper
• Silencing of AJAP1 expression by promoter methylation activates the Wnt/β-catenin signaling pathway to promote tumor proliferation and metastasis in salivary adenoid cystic carcinoma

  2023cites this paper
• Low levels of miR-34c in nasal washings as a candidate marker of aggressive disease in wood and leather exposed workers with sinonasal intestinal-type adenocarcinomas (ITACs)

  2022cites this paper
• miR-34a predicts the prognosis of advanced-stage external auditory canal squamous cell carcinoma

  2022influential citation
• Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions

  2022cites this paper
• Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation.

  2022cites this paper
• Functional analysis of the miR-145/Fascin1 cascade in canine oral squamous cell carcinoma.

  2022cites this paper
• Novel insights into noncanonical open reading frames in cancer.

  2022cites this paper
• Meta-analysis of miR-34 target mRNAs using an integrative online application

  2022cites this paper
• Methylation detection of circulating tumor cell miR-486-5p/miR-34c-5p in the progression of colorectal cancer

  2022cites this paper
• Value of Serum miR-34a and Ang-1 in Severity Evaluation and Prognosis of Neonatal Respiratory Distress Syndrome

  2022cites this paper
• Next generation sequencing reveals miR-431-3p/miR-1303 as immune-regulating microRNAs for active tuberculosis.

  2022cites this paper
• The emerging role of noncoding RNAs in the Hedgehog signaling pathway in cancer.

  2022cites this paper
• Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective

  2021cites this paper